Concepedia
Statistics
Publications
3
Citations
170
H-Index
Active since
2013
Affiliations
University of Bern(Current)
University Hospital of Bern
Merck (Germany)
Kei Mikami is an author at University of Bern specializing in cancer biology, liver physiology, and immunology.
Top concepts
HealthMedicineOncologyPathologyHepatologyImmunologyCell BiologyTumor BiologyCancer BiologyCancer Therapy
Publications per year
2013–2015
Antitumor Effect of SIRT1 Inhibition in Human HCC Tumor Models <i>In Vitro</i> and <i>In Vivo</i>
Simone Portmann, René Fahrner, Antje Lechleiter et al. · Molecular Cancer Therapeutics · 2013 · 113 citations
Immunology, Pathology, Cancer Biology +20
Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition–Associated Checkpoint Abrogation
Kei Mikami, Michaela Medová, Lluís Nisa et al. · Molecular Cancer Research · 2015 · 32 citations
KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET‐expressing tumor cells
Dominic Leiser, Michaela Medová, Kei Mikami et al. · Molecular Oncology · 2015 · 25 citations · Full text
1–3 of 3